Background-Lysophosphatidylcholine (LPC), a naturally occurring phospholipid metabolite, accumulates in the ischemic heart and causes extracellular K ϩ accumulation and action potential shortening. LPC has been incriminated as a biochemical trigger of lethal cardiac arrhythmias, but the underlying mechanisms remain poorly understood. Methods and Results-We studied the effect of 1-palmitoyl-LPC (Pal-LPC) on currents resulting from human ether-a-go-go-related gene (HERG) expression in human embryonic kidney (HEK) cells using whole-cell patch-clamp techniques. Bath application of Pal-LPC consistently and reversibly increased HERG current (I HERG ). The effects of Pal-LPC were apparent as early as 3 minutes after application of the drug, reached maximum within 10 minutes, and were reversible on washout. Pal-LPC increased I HERG at voltages between Ϫ20 and ϩ30 mV, with greater effects at stronger depolarization. However, Pal-LPC did not affect the voltage-dependence of I HERG activation. In contrast, Pal-LPC significantly shifted the inactivation curve toward more positive potentials, causing a mean 20.0Ϯ2.2 mV shift in half-inactivation voltage relative to control. Conclusions-Our results indicate that apart from being a well-recognized target for drug inhibition, I HERG can also be enhanced by natural substances. An increase in I HERG by Pal-LPC may contribute to K ϩ loss, abnormal electrophysiology, and arrhythmia occurrence in the ischemic heart. (Circulation. 2001;104:2645-2648.) 
L ysophosphatidylcholine (LPC) is a naturally occurring intracellular phospholipid metabolite that is present in a variety of mammalian tissues. 1 LPC accumulates rapidly in the heart during cardiac ischemia and in diabetic cardiomyopathy. 2 It has been incriminated as a biochemical trigger of lethal cardiac arrhythmias, [3] [4] [5] [6] [7] [8] and it promotes abnormal rhythmic activity, delayed afterdepolarizations, triggered activity, and intramyocardial reentry. Action potential duration (APD) shortening by LPC has been documented in rabbit atrial and ventricular cells, 4 guinea pig ventricular cells, 5 and canine ventricular cells 6 and Purkinje fibers. 3 LPC levels correlate with the occurrence of arrhythmias in ischemic and diabetic hearts. [7] [8] [9] Inhibitory effects on sodium current 10 and inwardly rectifying K ϩ current (I K1 ) 11 explain the conduction slowing and membrane depolarization produced by LPC, but the mechanisms underlying APD shortening remain incompletely understood. Reduced I K1 should, if anything, increase APD. A recent study by Goldhaber et al 12 reported that LPC (20 mol/L) decreases tissue K ϩ content by Ϸ15%, an effect associated with gradual APD shortening and increased K ϩ efflux. During acute myocardial ischemia, increased K ϩ efflux in the face of maintained Na ϩ /K ϩ pumping results in extracellular K ϩ accumulation, a key arrhythmogenic factor. Although increased K ϩ efflux can account for some of the important arrhythmogenic effects of LPC, how LPC increases K ϩ efflux is essentially unknown. Increased K ϩ conductance could account for APD abbreviation and could contribute to increased K ϩ efflux; however, LPC is not known to increase cardiac K ϩ -currents.
The human ether-a-go-go-related gene (HERG) encodes the rapid delayed rectifier K ϩ current (I Kr ), 13 a critically important cardiac repolarizing current in most animals, including humans. 14 Apart from being a molecular target for mutations that generate long-QT syndrome, HERG is also a prime pharmacological target for a wide range of drugs that block the HERG current (I HERG ) exclusively; this blockade either confers antiarrhythmic efficacy or produces proarrhythmic cardiotoxicity. 15 The present study was designed to investigate whether LPC can modulate I HERG and, if so, to characterize the biophysical components of this action.
Methods

Cell Culture
HEK293 cells stably expressing HERG (a kind gift from Drs Zhou and January, University of Wisconsin, Madison 16 ) were seeded in a 25-cm 2 , triangular, cell-culture flasks and grown in Dulbecco's modified eagle's medium supplemented with 10% heat-inactivated fetal bovine serum, 200-mol/L G418, 100 U/mL penicillin, and 100 g/mL streptomycin. The cells subcultured to Ϸ85% confluency were harvested by trypsinization and stored in Tyrode solution containing 0.5% BSA at 4°C. Electrophysiological recordings were conducted within 10 hours of storage.
Whole-Cell Patch-Clamp Recording
Patch-clamp techniques have been described in detail elsewhere. 14 Currents were recorded by whole-cell voltage-clamp with an Axopatch-200B amplifier (Axon Instruments). Borosilicate glass electrodes had tip resistances of 1 to 3 M⍀ when filled with (in mmol/L): GTP 0.1, potassium aspartate 110, KCl 20, MgCl 2 1, Mg-ATP 5, HEPES 10, and phosphocreatine 5 (pH 7.3). The extracellular solution contained (in mmol/L): NaCl 136, KCl 5.4, MgCl 2 1, HEPES 5, glucose 10, and CaCl 2 1 (pH 7.4). Experiments were conducted at 36Ϯ1°C. Junction potentials were zeroed before formation of the membrane-pipette seal. Series resistance and capacitance were compensated, and leak currents were subtracted. 1-Palmitoyl-LPC (Pal-LPC; Sigma) was dissolved directly into the bath solution at the desired concentrations immediately before each experiment. 1-Palmitoyl-lysophosphatidylglycerol (Avanti Polar Lipid) and membrane-permeable ceramide (Sigma) were used for negative controls.
Data Analysis
Group data are expressed as meanϮSEM. Comparisons among groups were made by ANOVA (F test), Bonferroni-adjusted t tests were used for multiple group comparisons, and paired t tests were used for single comparisons. A 2-tailed PϽ0.05 indicated statistically-significant difference. Nonlinear least-square curvefitting was performed with CLAMPFIT in pCLAMP 8.0 or Graphpad Prism.
Results
Bath application of Pal-LPC reversibly increased I HERG (Figures 1A and 1B) in a concentration-dependent manner (Figure 1D ). Pal-LPC increased I HERG at voltages between Ϫ20 and ϩ30 mV ( Figure 1B) , and the F-test indicated the effect was voltage-dependent (PϽ0.01, Figure 1C ). However, the half-maximum activation voltage, which was determined by the tail currents, was not affected by Pal-LPC (from control to LPC: Ϫ26Ϯ3 to Ϫ24Ϯ3 mV, PϾ0.05), nor was the slope factor k (from control to Pal-LPC: 8Ϯ1 to 9Ϯ1 mV, PϾ0.05). The effects of Pal-LPC were apparent (Ϸ37% the maximum) as early as 3 minutes after application of the drug, and they reached maximum within 10 minutes ( Figure 1E ). Under our experimental conditions, Ϸ2.5 minutes are required for the solution to circulate into the bathing chamber, and this implies that Pal-LPC effects took place within 0.5 to 1 minute of exposure. Neither 1-palmitoyl-lysophosphatidylglycerol (5 mol/L) nor membrane-permeable ceramide (50 mol/L) produced significant effects on I HERG (Figures 1F and 1G) .
Pal-LPC significantly shifted the inactivation curve toward more positive potentials (Figures 2A and 2B) , causing a mean 20.0Ϯ2.2 mV shift in half-maximum activation voltage for inactivation relative to control. Figure 2C shows Pal-LPCinduced percent change in currents at ϩ20 mV after prepulses to different voltages, and it indicates that Pal-LPC did not alter currents when inactivation was fully removed by prepulses to more negative voltages but it significantly increased current at prepulse voltages allowing for inactivation. The inactivation time constants determined by monoexponential fit to the decaying currents recorded at ϩ20 mV (Figure 2A ) were 4.8Ϯ0.4 and 6.9Ϯ0.9 ms for control and Pal-LPC, respectively (PϽ0.05). The recovery time constants measured by the inward currents during the hyperpolarizing prepulses were not significantly altered by Pal-LPC (from 1.9Ϯ0.1 to 1.7Ϯ0.2 ms, PϾ0.05).
Discussion
In this study, we demonstrated that Pal-LPC increases I HERG in HEK293 cells. The Pal-LPC-induced increase in I HERG is reversible and occurs within minutes of extracellular application. The current-enhancing effect is in large measure due to a substantial depolarizing shift in I HERG inactivation, such that more current is available at any given voltage within the activation range. Intracellular K ϩ loss and accompanying extracellular K ϩ accumulation impairs cardiac electrical activity and can also promote cell death through apoptosis, 17 thereby contributing to the pathophysiology of the ischemic myocardium. ATPsensitive K ϩ current (I KATP ) contributes significantly to the rapid increase in cellular K ϩ efflux and APD shortening during myocardial ischemia and hypoxia. However, during the first 10 minutes of ischemia in intact hearts, cytosolic ATP concentrations remain Ϸ2 orders of magnitude greater than the ATP concentration, thus causing half-maximal blockade of I KATP in excised membrane patches. 18 It is conceivable that membrane conductances other than I KATP may contribute to APD abbreviation and loss of intracellular K ϩ .
LPC, a class of lysophospholipids that accumulate in the cell membrane during acute myocardial ischemia, decreases peak but enhances sustained Na ϩ current, resulting in a noninactivated component in ventricular myocytes of various species. 10, 19, 20 LPC also reduces I K1 , 11 the major determinant of the membrane resting potential in cardiac cells. These findings can account for the conduction slowing and membrane depolarization caused by LPC, but they do not explain how LPC produces APD shortening [3] [4] [5] [6] and K ϩ loss. 12 Our observation regarding Pal-LPC effects on I HERG may explain, at least in part, the latter observations. Because Pal-LPC increased I HERG significantly in the range of plateau voltages (Ϫ10 to ϩ10 mV), it is quite possible that Pal-LPC promotes the repolarization of cardiac action potentials or APD shortening during acute ischemia and that Pal-LPC-induced I HERG enhancement could also contribute to K ϩ -efflux.
Many class III drugs produce their antiarrhythmic effects by acting on HERG/I Kr currents. In addition, a wide spectrum of non-antiarrhythmic agents can cause proarrhythmic effects (acquired long-QT syndrome) by inhibiting I HERG . 15 In the present study, we found that I HERG can also be enhanced. Furthermore, the mechanism of enhancement involved a substantial positive shift in I HERG inactivation voltagedependence. The rapid inactivation mechanism of I HERG is a distinct property and, to our knowledge, this is the first time that a shift in I HERG inactivation voltage-dependence has been shown to underlie a potentially significant endogenous pathophysiological mechanism. In addition to the potential intrinsic significance of this observation, it may open up new possibilities in exploring the regulation of HERG properties by membrane lipids.
Under ischemic conditions, LPC (normally present at 0.5% to 3.5% of total membrane phospholipids), increases to an extent that varies among different species and different tissue compartments. The typical LPC concentration range is 100 to 200 mol/L. 21 Assuming that Ϸ90% of LPC protein-bound, the free concentration of LPC is 10 to 20 mol/L. LPC, mainly Pal-LPC, [21] [22] [23] accumulation during cardiac ischemia is thought to occur predominantly in the extracellular space. 24 Thus, the concentration of Pal-LPC (5 mol/L) used in this study is likely relevant to pathophysiological situations. Figure 2 . A, I HERG recordings (with voltage protocol in inset) before and 10 minutes after LPC application. B, I HERG inactivation voltage-dependence. The tail current (I tail ) during the test pulse to ϩ20 mV at various prepulse potentials was normalized to the value for a prepulse to Ϫ120 mV. Symbols are meanϮSEM of 13 experiments, and curves are Boltzmann fits. Half-maximum activation voltage for inactivation was shifted by LPC from Ϫ40.9Ϯ3.4 to Ϫ21.2Ϯ1.8 mV (PϽ0.001). C, Ratio of I HERG with LPC over control (PϽ0.001 for voltage-dependence by ANOVA). *PϽ0.05, **PϽ0.01, and ***PϽ0.001 for LPC versus control.
